These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27103462)

  • 1. Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder.
    Shim SH; Yoon HJ; Bak J; Hahn SW; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():237-44. PubMed ID: 27103462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).
    Retz W; Retz-Junginger P
    Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S35-43. PubMed ID: 25231833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
    Olfson M
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder.
    Buitelaar J; Asherson P; Soutullo C; Colla M; Adams DH; Tanaka Y; Haynes VS; Escobar R; Upadhyaya H
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1611-21. PubMed ID: 26169574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
    Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
    Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.
    Rostain AL
    Postgrad Med; 2008 Sep; 120(3):27-38. PubMed ID: 18824823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP; Bettinger TL; Patel NC; Crismon ML
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
    Waxmonsky JG
    Essent Psychopharmacol; 2005; 6(5):262-76. PubMed ID: 16222911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging markers for the prediction of treatment response to Methylphenidate in ADHD.
    Skokauskas N; Hitoshi K; Shuji H; Frodl T
    Eur J Paediatr Neurol; 2013 Nov; 17(6):543-51. PubMed ID: 23672833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
    Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A current update on ADHD pharmacogenomics.
    Kieling C; Genro JP; Hutz MH; Rohde LA
    Pharmacogenomics; 2010 Mar; 11(3):407-19. PubMed ID: 20235795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.